US$ 26.29
glp 1 agonist fda approval FDA-Approved Dosages and Indications for GLP-1 and Dual GIP/GLP-1 FDA just approved orforglipron (Foundayo),
Description
How big of a shift do you think we would see for seniors if Medicare made this pilot more permanent
doi: 10.2337/diab.42.5.658 95 ReedJBainSKanamarlapudiV
[DOI] [PMC free article] [PubMed] [Google Scholar] 39

Compounded GLP-1s are custom-made alternatives to brand drugs designed to meet a specific patient's needs

( 10.1152/ajprenal.00527.2014) [DOI] [PubMed] [Google Scholar] 37.Baggio LL, Yusta B, Mulvihill EE, Cao X, Streutker CJ, Butany J, Cappola TP, Margulies KB, Drucker DJ

GLP-1 is a multifaceted hormone, and the use of its analogs is associated with broad metabolic effects: they increase insulin secretion, decrease glucagon release, increase glucose uptake in muscles, decrease glucose production in the liver, improve lipid profile, slow gastric emptying, and increase satiety leading to weight loss (40)
